Panacea Venture, a venture capital firm backed by Kleiner Perkins Caufield & Byers (KPCB) China partners James Huang and Hai Mai, has hit the final close of its new healthcare fund in an oversubscribed fundraise at $180.5 million, according to a statement.
The fund – Panacea Venture Healthcare Fund I – had an original target of $150 million and received support from a broad group of institutional investors globally, including endowments, foundations, sovereign wealth funds, pension programs, consultants, fund-of-funds, asset managers, and family offices.
